Benralizumab for Chronic Spontaneous Urticaria.

Jonathan A. Bernstein,Umesh Singh,Marepalli B. Rao,Karen Berendts,Xiang Zhang,Diya F. Mutasim

Benralizumab for Chronic Spontaneous Urticaria.

2020

Jonathan A. Bernstein
Umesh Singh
Marepalli B. Rao
Karen Berendts
Xiang Zhang
Diya F. Mutasim

Benralizumab for Chronic Spontaneous Urticaria Benralizumab, an anti–interleukin-5-receptor antibody, was evaluated in a 24-week study involving 12 patients with chronic spontaneous urticaria. The ...

Keywords:

Immunology
Antibody
Benralizumab
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations